Detalhe da pesquisa
1.
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies.
Br J Cancer
; 130(1): 135-142, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938348
2.
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy.
Ann Oncol
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704093
3.
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Ann Oncol
; 29(12): 2288-2295, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304498
4.
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer.
Ann Oncol
; 29(5): 1189-1194, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462248
5.
ESMO Guidance for Reporting Oncology real-World evidence (GROW).
Ann Oncol
; 34(12): 1097-1112, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848160
6.
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation.
Ann Oncol
; 29(8): 1800-1806, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860358
7.
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline.
Ann Oncol
; 33(9): 878-892, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462007
8.
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial.
Ann Oncol
; 28(6): 1346-1351, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383677
9.
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
Ann Oncol
; 28(12): 3009-3014, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045518
10.
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
Ann Oncol
; 27(12): 2224-2229, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789469
11.
Toward the molecular dissection of peritoneal pseudomyxoma.
Ann Oncol
; 27(11): 2097-2103, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502722
12.
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
Ann Oncol
; 26(10): 2092-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153495
13.
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Ann Oncol
; 26(4): 675-682, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488686
14.
Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer.
Br J Cancer
; 110(4): 1001-7, 2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423916
15.
Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al.
Ann Oncol
; 30(4): 658-659, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698648
16.
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.
Ann Oncol
; 25(2): 404-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379162
17.
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.
Ann Oncol
; 25(3): 694-699, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24510315
18.
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials.
ESMO Open
; 9(3): 102941, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452437
19.
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.
ESMO Open
; 9(5): 102992, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626634
20.
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues.
Sci Rep
; 14(1): 13138, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849509